Cb5083

CB5083 | ≥99%(HPLC) | p97 inhibitor | AdooQ®

CB-5083 | p97 AAA ATPase/VCP Inhibitor | MedChemExpress

CB-5083 | p97 AAA ATPase Inhibitor | TargetMol

CB-5083 is a Selective and Orally Bioavailable p97 Inhibitor - Immune ...

Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation ...

CB 5083 | p97 ATPase | Tocris Bioscience

Structural Basis of p97 Inhibition by the Site-Selective Anticancer ...

Structural Basis of p97 Inhibition by the Site-Selective Anticancer ...

Molecular docking of CB-5083 and NMS-873 into VCP. (a) A structural ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

CB-5083 is an Orally Active AAA ATPase p97 Inhibitor for Multiple ...

Atpγs | Millipore | Bioz

Structural Basis of p97 Inhibition by the Site-Selective Anticancer ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

(PDF) VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

p97 inhibition by CB-5083 suppresses HCoV replication in H1299 cells ...

CB-5083, an inhibitor of P97, suppresses osteosarcoma growth and stem ...

CB-5083, an inhibitor of P97, suppresses osteosarcoma growth and stem ...

VCP/p97 is essential for SP retrotranslocation. (A) The VCP/p97 ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

Full article: Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

Structural Basis of p97 Inhibition by the Site-Selective Anticancer ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Full article: Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in ...

301 Moved Permanently

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model ...

Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

CB-5083 | p97 AAA ATPase Inhibitor | CAS 1542705-92-9 | Selleck Chemicals

Full article: Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in ...

CB-5083, an inhibitor of P97, suppresses osteosarcoma growth and stem ...

CB-5083 ATPase inhibitor | Selleck Chemicals

p97 | p97 Inhibitor Review

CB-5083 ATPase inhibitor | Selleck Chemicals

(PDF) Proteomics analysis reveals the differential impact of the p97 ...

Exploring in vivo combinatorial chemo-immunotherapy: Addressing p97 ...

A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent ...

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model ...

M50-mediated IRE1 degradation is blocked by the p97/VCP inhibitor ...

(PDF) VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model ...

NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent ...

CB-5083 - p97 AAA ATPase Inhibitor. CAS# 1542705-92-9 – Xcess Biosciences

(PDF) A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a ...

Inhibitors of the ATPase p97/VCP: From basic research to clinical ...

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model ...

A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Allosteric p97 Inhibitors Can Overcome Resistance to ATP‐Competitive ...

Full article: Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in ...

RepID-deficient cancer cells are sensitive to p97/VCP inhibitor. a, b ...

Treatment with p97 inhibitors induces apoptosis in MCL cells. a, b ...

Molecular docking of CB-5083 and NMS-873 into VCP. (a) A structural ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Adapted ATPase domain communication overcomes the cytotoxicity of p97 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Synergistic activity of CB-5083 and vincristine. BALL1 and OP1 cells ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Valosin-containing protein (VCP/p97) inhibition reduces viral clearance ...

Covalent Modifiers: A Covalent p97/VCP ATPase Inhibitor can overcome ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Valosin-containing protein (VCP/p97) inhibition reduces viral clearance ...

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

(PDF) Pre-Clinical Activity of the Novel, First-in-Class p97 Inhibitor ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Valosin-containing protein (VCP/p97) inhibition reduces viral clearance ...

ATPase抑制剂 | ATPase Inhibitor

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Differential cellular effects between UPCDC-30245 and CB-5083 or ...

Valosin-containing protein (VCP/p97) inhibition reduces viral clearance ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Proposed desensitization mechanism of p97 to its ATP-competitive and ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

CB-5083-resistant cell lines harbor heterozygous mutations at exon 12 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Frontiers | Discovery of novel benzylquinazoline molecules as p97/VCP ...

p97 inhibitors. (A) Table of a selection of known p97 inhibitors ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Targeting the AAA ATPase p97 as an Approach to Treat Cancer through ...

Treatment with p97 inhibitors induces apoptosis in MCL cells. a, b ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Cb-5083 Experimental Drug Molecule #2 Poster by Dr Tim Evans / Science ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

(PDF) p97 Inhibitor CB-5083 Blocks ERAD in Trypanosoma brucei

A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 ...

Cellular localization of p97. (A) MCF-10A cells were plated for 24 ...

Inhibition of p97 potentiates the effect of PARPi a, Inhibition of p97 ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Adapted ATPase domain communication overcomes the cytotoxicity of p97 ...

UBXD8 knock out or p97 inhibition results in increased ERMCS a ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Targeting the AAA ATPase p97 as an Approach to Treat Cancer through ...

Discovery of a First-in-Class, Potent, Selective, and Orally ...

Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive ...

1542705-92-9型p97抑制剂(CB-5083)大量库存促销价格,详情介绍-960化工网 – 960化工网

Discovery of a First-in-Class, Potent, Selective, and Orally ...